US OptionsDetailed Quotes
TZOO241220C17500
- 2.32
- +0.70+43.21%
15min DelayClose Nov 22 16:00 ET
2.32High2.32Low
2.32Open1.62Pre Close5 Volume71 Open Interest17.50Strike Price1.16KTurnover52.68%IV0.00%PremiumDec 20, 2024Expiry Date2.32Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8316Delta0.0883Gamma7.48Leverage Ratio-0.0149Theta0.0103Rho6.22Eff Leverage0.0136Vega
Travelzoo Stock Discussion
looks good eps beats estimates may be money double opportunity
Travelzoo presents a prominent swing trading opportunity which is due to recent earnings, positive news catalysts, and the proximity to its 52-week high. The company's financials indicate profitability with a strong cash flow and a healthy balance sheet, further reinforced by a positive sentiment towards its stock. It's evident from recent price targets being raised by analysts alongside strategic decisions like stock buyback programs to enhance shareholder value. Despite o...
• $Allstate (ALL.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $165 (from $145)
• $DigitalBridge Group (DBRG.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $7
• $Garmin (GRMN.US)$: BofA Securities Upgrades to Buy from Neutral - PT $140 (from $165)
• $Guidewire Software (GWRE.US)$: JMP Securities Upgrades to Market Outperform from Market Perform - PT $110
• $MongoDB (MDB.US)$: UBS Upgrades to Buy from Neutral - PT $450 (from $345)...
Sometimes I like to go through the biggest losers of the day and pick out the diamonds in the rough I just had a bad day.
$Aarons Holdings Co Inc (AAN.US)$ diamond in the rough
$Baudax Bio (BXRX.US)$
$Esperion Therapeutics (ESPR.US)$
$Proteostasis Therapeutics (PTI.US)$
No comment yet